Jade Biosciences, Inc. · NASDAQ:JBIO
Ra Capital Management, L.P. reported a 4.10% stake in Jade Biosciences, Inc. (Schedule 13D/A)
Event Apr 28, 2025 · Filed Apr 30, 2025
Ra Capital Management, L.P. reported a 4.10% stake in Jade Biosciences, Inc., 1,324,954 shares, with active intent on Apr 28, 2025. Filed Apr 30, 2025 (Schedule 13D/A).
- Stake
- 4.10%
- Shares
- 1,324,954
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 4.10% | 1,324,954 |
| Peter Kolchinsky | 4.10% | 1,324,954 |
| Rajeev Shah | 4.10% | 1,324,954 |
| RA Capital Healthcare Fund, L.P. | 4.00% | 1,287,858 |
Source
Related
- Jade Biosciences, Inc.
- Ra Capital Management, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Oct 16, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026